Jubilant Life Sciences raises Rs 90 cr through commercial papers

Tenure of the instrument is 53 days and date of maturity is January 18, 2021, Jubilant Life Sciences said in a regulatory filing. Commercial paper is an unsecured money market instrument issued in the form of a promissory note. Shares of Jubilant Life Sciences closed at Rs 719 per scrip on BSE, up 1.38 per cent from its previous close.


PTI | New Delhi | Updated: 26-11-2020 15:58 IST | Created: 26-11-2020 15:58 IST
Jubilant Life Sciences raises Rs 90 cr through commercial papers
  • Country:
  • India

Drug firm Jubilant Life Sciences on Thursday said it has issued commercial papers worth Rs 90 crore. Tenure of the instrument is 53 days and date of maturity is January 18, 2021, Jubilant Life Sciences said in a regulatory filing.

Commercial paper is an unsecured money market instrument issued in the form of a promissory note. It was introduced in India in 1990 to enable highly rated corporate borrowers to diversify their sources of short-term borrowings and to provide an additional instrument to investors. Shares of Jubilant Life Sciences closed at Rs 719 per scrip on BSE, up 1.38 per cent from its previous close.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback